← Browse by Condition
Medical Condition
glioblastoma multiforme gbm
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 1
NCT06595186 Phase 2
Recruiting
JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)
Enrollment
25 pts
Location
China
Sponsor
JenKem Technology Co., Ltd.
NCT06632236 Phase 1
Recruiting
5G-EMERALD: Amivantamab in Malignant Brain Tumours
Enrollment
12 pts
Location
United Kingdom
Sponsor
Institute of Cancer Research, ...